Drug Design Novel Advances in the Omics Field and Applications
Right before the COVID-19 pandemic declared by the World Health Organization (WHO), life sciences have incited novel areas of studies that revolutionize the health sector. They are the studies of structural bioinformatics, pharmacogenomics, and metabolomics. The structural bioinformatics field is th...
| Format: | eBook |
|---|---|
| Language: | English |
| Published: |
IntechOpen
2021
|
| Subjects: | |
| Online Access: | Open Access: DOAB: description of the publication Open Access: DOAB, download the publication |
| LEADER | 02325namaa2200409uu 4500 | ||
|---|---|---|---|
| 001 | doab130927 | ||
| 003 | oapen | ||
| 005 | 20231201 | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 231201s2021 xx |||||o ||| 0|eng d | ||
| 020 | |a 9781789847529 | ||
| 020 | |a 9781789847536 | ||
| 020 | |a 9781789852011 | ||
| 020 | |a intechopen.87640 | ||
| 024 | 7 | |a 10.5772/intechopen.87640 |2 doi | |
| 040 | |a oapen |c oapen | ||
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a MKG |2 bicssc | |
| 720 | 1 | |a Aditya Parikesit, Arli |4 edt | |
| 720 | 1 | |a Aditya Parikesit, Arli |4 oth | |
| 245 | 0 | 0 | |a Drug Design |b Novel Advances in the Omics Field and Applications |
| 260 | |b IntechOpen |c 2021 | ||
| 300 | |a 1 online resource (158 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |f Unrestricted online access |2 star | |
| 520 | |a Right before the COVID-19 pandemic declared by the World Health Organization (WHO), life sciences have incited novel areas of studies that revolutionize the health sector. They are the studies of structural bioinformatics, pharmacogenomics, and metabolomics. The structural bioinformatics field is the very foundation of drug design research, as it provides insight into the molecular simulations and interactions between the biomolecules and the drug candidates. Secondly, pharmacogenomics is the starting point of any efforts in developing personalized medicine. Lastly, metabolomics provides instrumentation to elicit biomarkers for various diseases and health conditions. These studies have enabled current accelerated effort in COVID-19 research, as well as other communicable and non-communicable diseases. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/3.0/ |2 cc |u https://creativecommons.org/licenses/by/3.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Pharmacology |2 bicssc | |
| 653 | |a bioactive compounds, drug discovery, genomics, proteomics, density functional theory, metabolites | ||
| 793 | 0 | |a DOAB Library. | |
| 856 | 4 | 0 | |u https://directory.doabooks.org/handle/20.500.12854/130927 |7 0 |z Open Access: DOAB: description of the publication |
| 856 | 4 | 0 | |u https://mts.intechopen.com/storage/books/9831/authors_book/authors_book.pdf |7 0 |z Open Access: DOAB, download the publication |